Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry

Table 3 Logistic regression analysis for the predictors of stent thrombosis

	Univariable analysis			Multivariable model 1			Multivariable model 2
	OR	95% CI	p-value	OR^a	95% CI	p-value	OR^a	95% CI	p-value
All definite ST
Cancer	1.50	0.97–2.33	0.067	1.54	0.97–2.45	0.067
Cancer type classified by the diagnosed timing (vs. non-cancer)
Currently diagnosed cancer	2.69	1.15–6.29	0.023				3.21	1.30–7.97	0.012
Previously diagnosed cancer	1.35	0.81–2.26	0.25				1.27	0.75–2.14	0.38
EST
Cancer	1.02	0.55–1.89	0.95	1.01	0.51–2.00	0.97
Cancer type classified by the diagnosed timing (vs. non-cancer)
Currently diagnosed cancer	1.20	0.33–4.43	0.78				0.86	0.17–4.26	0.86
Previously diagnosed cancer	0.98	0.49–1.95	0.95				1.05	0.50–2.19	0.90
LST
Cancer	2.54	0.95–6.80	0.064	2.80	0.92–8.55	0.071
Cancer type classified by the diagnosed timing (vs. non-cancer)
Currently diagnosed cancer	4.35	0.27–70.8	0.30				9.77	0.55–172.4	0.12
Previously diagnosed cancer	2.37	0.83–6.74	0.11				2.35	0.71–7.74	0.16
VLST
Cancer	2.34	1.02–5.34	0.045	2.40	1.02–5.65	0.046
Cancer type classified by the diagnosed timing (vs. non-cancer)
Currently diagnosed cancer	7.40	1.71–32.0	0.007				8.73	1.92–39.7	0.005
Previously diagnosed cancer	1.39	0.48–3.97	0.54				1.32	0.44–3.94	0.62

CI confidence interval, EST early stent thrombosis, LST late stent thrombosis, OR odds ratio, ST stent thrombosis, VLST very late stent thrombosis
^aAdjusted for covariates listed in Table 1

ISSN: 1477-9560